Accuracy of pharmaceutical advertisements in medical journals

Lancet

Volumn 361, Issue 9351, 2003, Pages 27-32

  Villanueva, Pilar ^a   Peiró, Salvador ^a,b   Librero, Julián ^a   Pereiró, Inmaculada ^c  

^a Fund Inst de Invest Serv Salud   (Spain)

^b Generalitat Valenciana   (Spain)

^c Instituto Social de la Marina   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT;

ACCURACY; ADVERTIZING; ARTICLE; BIOSAFETY; CONFIDENCE INTERVAL; MEDICAL LITERATURE; PRIORITY JOURNAL; SPAIN;

EID: 0037417526     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)12118-6     Document Type: Article

References (28)

1. Anonymous. Can the advertisements in a reputable medical journal promote quackery? JAMA 1894; 22: 958.
2. Rennie D. Editors and advertisements: what responsibility do editors have for the advertisements in their journals? JAMA. 265:1991;2394-2396.
3. Wilkes M.S., Kravitz R.L. Policies, practices, and attitudes of North American medical journal editors. J Gen Intern Med. 10:1995;443-450.
4. Wilkes M.S., Doblin B.H., Shapiro M.F. Pharmaceutical advertising in leading medical journals: experts' assessments. Ann Intern Med. 116:1992;912-919.
5. Mindell J., Kemp T. Evidence based advertising? Only two fifths of advertisements cited published, peer reviewed references. BMJ. 315:1997;1622.
6. Lexchin J., Holbrook A. Methodologic quality and relevance of references in pharmaceutical advertisements in a Canadian medical journal. Can Med Assoc J. 151:1994;47-54.
7. Smart S., Williams C. Evidence based advertising? Half of drug advertisements in BMJ over six months cited no supporting evidence. BMJ. 315:1997;1622-1623.
8. Greenhalgh T. More convincing evidence of efficacy needs to be cited. BMJ. 315:1997;1623.
9. Healing E. Data in drug advertisements. BMJ. 308:1994;474-475.
10. Bero L.A., Galbraith A., Rennie D. The publication of sponsored symposiums in medical journals. N Engl J Med. 327:1992;1135-1140.
11. Sackett D.L., Richardson W.S., Rosenberg W., Haynes R.B. Evidence-Based Medicine: how to practice and teach EBM. 1997;Churchill-Livingstone, London.
12. Wang T.J., Ausiello J.C., Stafford R.S. Trends in antihypertensive drug advertising, 1985-1996. Circulation. 99:1999;2055-2057.
13. Kessler D.A., Rose J.L., Temple R.J., Schapiro R., Griffin J.P. Therapeutic-class wars: drug promotion in a competitive marketplace. N Engl J Med. 331:1994;1350-1353.
14. Angell M. Is academic medicine for sale? N Engl J Med. 342:2000;1516-1518.
15. Real Decreto 1416/1994, de 25 de junio, por el que se regula la publicidad de los medicamentos de uso humano [Royal Decree 1416/1994, June 25, which regulates advertisement of drugs for human use]. Boletin Oficial del Estado 1994; July 29.
16. Kessler D.A., Pines W.L. The federal regulation of prescription drug advertising and promotion. JAMA. 264:1990;2409-2415.
17. Smith M.C. Drug product advertising and prescribing: a review of the evidence. Am J Hosp Pharm. 34:1977;1208-1224.
18. Avorn J., Chen M., Hartley R. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med. 73:1982;4-8.
19. Caudill T.S., Lurie N., Rich E.C. The influence of pharmaceutical industry advertising on physician prescribing. J Drug Issues. 22:1992;331-338.
20. The influence of drug advertisements. Lancet 1982; 2: 1257-58.
21. Perman E. Voluntary control of drug promotion in Sweden. N Engl J Med. 323:1990;616-617.
22. Lexchin J. Code of marketing practices: voluntary self-regulation for the Pharmaceutical Manufacturers Association of Canada. Can Fam Physician. 43:1997;1997.
23. Mansfield P.R. MaLAM, a medical lobby for appropriate marketing of pharmaceuticals. Med J Aust. 167:1997;590-592.
24. Herxheimer A., Collier J. Promotion by the British pharmaceutical industry, 1983-88: a critical analysis of self regulation. BMJ. 300:1990;307-311.
25. Lexchin J. Canadian marketing codes: how well are they controlling pharmaceutical promotion. Int J Health Serv. 24:1994;91-104.
26. Roughead E.E., Gilbert A.L., Harvey K.J. Self-regulatory codes of conduct: are they effective in controlling pharmaceutical representatives' presentations to general medical practitioners? Int J Health Serv. 28:1998;269-279.
27. Carandang E.D., Moulds R.F. Pharmaceutical advertisements in Australian medical publications - have they improved? Med J Aust. 161:1994;671-672.
28. Medical Lobby for Appropriate Marketing. Available at: http://www.camtech.net.au/malam/bibliogr.htm. (accessedAug 13, 2000).